Limitations of conventional treatment options for heparin-induced thrombocytopenia.

Warkentin, T E

Limitations of conventional treatment options for heparin-induced thrombocytopenia. [electronic resource] - Seminars in hematology Oct 1998 - 17-25; discussion 35-6 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

0037-1963


Ancrod--therapeutic use
Anticoagulants--therapeutic use
Chondroitin Sulfates--therapeutic use
Dermatan Sulfate--therapeutic use
Drug Combinations
Heparin--adverse effects
Heparin, Low-Molecular-Weight--therapeutic use
Heparitin Sulfate--therapeutic use
Humans
Thrombocytopenia--chemically induced
Warfarin--adverse effects